AmerisourceBergen to buy PharMEDium Healthcare for $2.575 billion in cash
Article continues below
The acquisition is expected to be $0.22 to $0.26 accretive to AmerisourceBergen.
The transaction is subject to regulatory review and other customary closing conditions, and is expected to close in the first quarter of fiscal 2016, which ends December 31, 2015.
This acquisition was not contemplated in the previous guidance the Company gave for adjusted earnings per share growth in fiscal 2016 in the low teens range on a percentage basis.
Therefore, upon closing, the contribution from the acquisition will be incremental to our previous expectations. ■